Otto Bremer Trust's Form 4 filing
Old National BancorpONB · filed Mar 2, 2026
- Accession no.
- 0002064726-26-000002
- Filed
- Mar 2, 2026
- Trade date
- Feb 26, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction. Open-market sales total $50.0M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Otto Bremer TrustCIK 0002064726 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | Common Stock | SSaleDisposed | −1,926,782 | $25.95F1 | −$49,999,992.9 | 41,210,548 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Shares of common stock of the Issuer (the "Shares") sold pursuant to an agreement between the Issuer and the trustees of the Reporting Person (the "Trustees"), at a purchase price of $25.95 per Share, which per Share price was agreed upon between the Issuer and the Trustees on February 11, 2026, based on the range of intraday trading prices for the Issuer's common stock on the NASDAQ Stock Exchange on that date. The sale of the Shares closed on February 26, 2026. The Shares were sold for investment portfolio diversification purposes of the Reporting Person.
Referenced by the price of 1 transaction in Table I.
Remarks
Solely for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the Reporting Person may be deemed to be a director-by-deputization by virtue of the Reporting Person's one-time contractual right to designate a Trustee for appointment to the board of directors of the Issuer pursuant to the Investor Agreement by and between the Trustees and the Issuer, dated November 25, 2024, under which the Issuer appointed one of the Trustees as a director of the Issuer, effective May 1, 2025, to serve in accordance with the corporate governance guidelines and standards applicable to all Issuer directors.